References
- Dietrich, J., Lacagnina, M., Gass, D., Richfield, E., Mayer-Pröschel, M., Noble, M., Torres, C., & Pröschel, C. (2005, March). EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nature Medicine, 11, 277–283. https://doi.org/https://doi.org/10.1038/nm1195
- Fogli, A., Rodriguez, D., Eymard-Pierre, E., Bouhour, F., Labauge, P., Meaney, B. F., Zeesman, S., Kaneski, C. R., Schiffmann, R., & Boespflug-Tanguy, O. (2003, June). Ovarian failure related to eukaryotic initiation factor 2B mutations. The American Journal of Human Genetics, 72, 1544–1550. https://doi.org/https://doi.org/10.1086/375404
- Fogli, A., Schiffmann, R., Bertini, E., Ughetto, S., Combes, P., Eymard-Pierre, E., Kaneski, C. R., Pineda, M., Troncoso, M., Uziel, G., Surtees, R., Pugin, D., Chaunu, M. P., Rodriguez, D., & Boespflug-Tanguy, O. (2004, May). The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology, 62, 1509–1517. https://doi.org/https://doi.org/10.1212/01.WNL.0000123259.67815.DB
- Hamilton, E. M. C., Van Der Lei, H. D. W., Vermeulen, G., Gerver, J. A. M., Lourenço, C. M., Naidu, S., Mierzewska, H., Gemke, R. J. B. J., De Vet, H. C. W., Uitdehaag, B. M. J., Lissenberg-Witte, B. I., & van der Knaap, M. S. (2018 August). Natural history of vanishing white matter. Annals of Neurology, 84, 274–288. https://doi.org/https://doi.org/10.1002/ana.25287
- La Piana, R., Vanderver, A., van der Knaap, M., Roux, L., Tampieri, D., Brais, B., & Bernanrd, G. (2012). Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation. Archives of Neurology, 69, 765–768. https://doi.org/https://doi.org/10.1001/archneurol.2011.1942
- Labauge, P., Horzinski, L., Ayrignac, X., Blanc, P., Vukusic, S., Rodriguez, D., Mauguiere, F., Peter, L., Goizet, C., Bouhour, F., Denier, C., Confavreux, C., Obadia, M., Blanc, F., De Sèze, J., Fogli, A., & Boespflug-Tanguy, O. (2009, August). Natural history of adult-onset eIF2B-related disorders: A multi-centric survey of 16 cases. O Brain, 132, 2161–2169. https://doi.org/https://doi.org/10.1093/brain/awp171
- Lauritzen, M., Dreier, J. P., Fabricius, M., Hartings, J. A., Graf, R., & Strong, A. J. (2011). Clinical relevance of cortical spreading depression in neurological disorders: Migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. Journal of Cerebral Blood Flow & Metabolism, 31, 17–35. https://doi.org/https://doi.org/10.1038/jcbfm.2010.191
- Pronk, J. C., Van Kollenburg, B., Scheper, G. C., & van der Knaap, M. S. (2006). Vanishing white matter disease: A review with focus on its genetics. Mental Retardation and Developmental Disabilities Research Reviews, 12, 123–128. https://doi.org/https://doi.org/10.1002/mrdd.20104
- Ramaswamy, V., Chan, A. K., & Kolski, H. K. (2006). Vanishing white matter disease with periodic (Paroxysmal) hemiparesis. Pediatric Neurology, 35, 65–68. https://doi.org/https://doi.org/10.1016/j.pediatrneurol.2005.12.014
- Robinson, M. E., Rossignol, E., Brais, B., Rouleau, G., Arbour, J. F., & Bernard, G. (2014). Vanishing white matter disease in French-Canadian patients from Quebec. Pediatric Neurology, 51, 225–232. https://doi.org/https://doi.org/10.1016/j.pediatrneurol.2014.05.006
- Russell, M. B., & Ducros, A. (2011, May). Sporadic and familial hemiplegic migraine: Pathophysiological mechanisms, clinical characteristics, diagnosis, and management. The Lancet Neurology, 10, 457–470. https://doi.org/https://doi.org/10.1016/S1474-4422(11)70048-5
- Terumitsu-Tsujita, M., Kitaura, H., Miura, I., Kiyama, Y., Goto, F., Muraki, Y., Ominato, S., Hara, N., Simankova, A., Bizen, N., Kashiwagi, K., Ito, T., Toyoshima, Y., Kakita, A., Manabe, T., Wakana, S., Takebayashi, H., & Igarashi, H. (2020). Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: A vanishing white matter disease model. Journal of Neurochemistry, 154, 25–40. https://doi.org/https://doi.org/10.1111/jnc.14887
- van der Knaap, M. S., Fogli, A., Boespflug-Tanguy, O., Abbink, T. E. M., & Schiffmann, R. (2003 February 20). Childhood Ataxia with central nervous system hypomyelination/vanishing white matter. [Updated 2019 Apr 4] M. P. Adam, H. H. Ardinger, R. A. Pagon, et al., Eds. GeneReviews® [Internet]. University of Washington, Seattle. 1993–2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1258/
- van der Knaap, M. S., Pronk, J. C., & Scheper, G. C. (2006, May). Vanishing white matter disease. The Lancet Neurology, 5, 413–423. Review. https://doi.org/https://doi.org/10.1016/S1474-4422(06)70440-9
- Van Der Lei, H. D. W., van Berkel, C. G. M., van Wieringen, W. N., Brenner, C., Feigenbaum, A., Mercimek-Mahmutoglu, S., Philippart, M., Tatli, B., Wassmer, E., Scheper, G. C., & van der Knaap, M. S. (2010, October). Genotype–phenotype correlation in vanishing white matter disease. Neurology, 75, 1555–1559. https://doi.org/https://doi.org/10.1212/WNL.0b013e3181f962ae
- Wei, C., Qin, Q., Chen, F., Zhou, A., Wang, F., Zuo, X., Chen, R., Lyu, J., & Jia, J. (2019, August 22). Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia. BMC Neurology, 19, 203. https://doi.org/https://doi.org/10.1186/s12883-019-1429-9